SCHEMBL7885140

SCHEMBL7885140

O=C(Nn1nc(-c2ccccc2)c2ccccc2c1=O)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 1/20 0.54
▸ HPGD P15428 4/20 0.50
▸ MEN1 O00255 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ TSHR P16473 1/20 0.50
▸ L3MBTL1 Q9Y468 2/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48
▸ SMN1; SMN2 Q16637 4/20 0.47
▸ MAPT P10636 2/20 0.47
▸ ALDH1A1 P00352 3/20 0.47
▸ KDM4E B2RXH2 1/20 0.46
▸ TP53 P04637 1/20 0.46
▸ POLB P06746 1/20 0.46
▸ THRB P10828 1/20 0.46
▸ PKM P14618 1/20 0.46
▸ BLM P54132 1/20 0.46
▸ CTDSP1 Q9GZU7 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ EGFR P00533 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7892210 0.81 ALDH1A1 (0.52) ALOX15HPGDMEN1KMT2ATSHR
SCHEMBL7894602 0.78 ALDH1A1 (0.51) ALOX15HPGDMEN1KMT2ATSHR
SCHEMBL7896107 0.77 MAPT (0.48) ALOX15HPGDMEN1KMT2ATSHR
SCHEMBL7892188 0.77 ALDH1A1 (0.53) ALOX15HPGDMEN1KMT2ATSHR
SCHEMBL1790108 0.75 MAPT (0.56) ALOX15HPGDMEN1KMT2ATSHR
SCHEMBL1788479 0.75 ALDH1A1 (0.59) ALOX15HPGDMEN1KMT2ANPSR1
SCHEMBL1786996 0.75 MEN1 (0.48) ALOX15HPGDMEN1KMT2ATSHR
SCHEMBL30794643 0.75 MAPT (0.56) ALOX15HPGDMEN1KMT2ATSHR
SCHEMBL30795705 0.75 ALDH1A1 (0.59) ALOX15HPGDMEN1KMT2ANPSR1
SCHEMBL30795813 0.75 MEN1 (0.48) ALOX15HPGDMEN1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6180629-B1 INDUCING OR PROMOTING APOPTOSIS AND FOR ARRESTING UNCONTROLLED NEOPLASTIC CELL PROLIFERATION, INCLUDING PRECANCEROUS AND CANCEROUS LESIONS CELL PATHWAYS, INC. 2001-01-30 — — US disclosed
Send feedback